Daniel I Woronow MD
Adult Congenital Heart Disease, Interventional Cardiology
Assistant Professor, Medicine, Georgetown University School of Medicine
Join to View Full Profile
12609 Celtic CTRockville, MD 20850
Phone+1 301-367-3856
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Daniel Woronow, MD is a cardiologist in Rockville, Maryland. He is currently licensed to practice medicine in Maryland, Tennessee, and Florida. He is an Assistant Professor at Georgetown University School of Medicine.
Education & Training
Rhode Island Hospital/Brown University HealthFellowship, Cardiovascular Disease, 1981 - 1983
University of MarylandResidency, Internal Medicine, 1978 - 1981
Johns Hopkins University School of MedicineClass of 1978
Certifications & Licensure
DC State Medical License 1983 - 2027
FL State Medical License 1993 - 2027
MD State Medical License 1979 - 2025
TN State Medical License 2013 - 2015
OK State Medical License 1987 - 2010
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Prolonged Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Review of Postmarketing Cases.Daniel Woronow, Christine Chamberlain, Monika Houstoun, Monica Muñoz
Endocrine Practice. 2024-07-01 - 8 citationsValsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study.Efe Eworuke, Mayura Shinde, Laura Hou, Michael J Paterson, Peter Bjødstrup Jensen
BMJ Open. 2023-04-17 - 13 citationsAcute Cholecystitis Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists Reported to the US Food and Drug Administration.Daniel Woronow, Christine Chamberlain, Ali Niak, Mark Avigan, Monika Houstoun
JAMA Internal Medicine. 2022-10-01
Press Mentions
FDA Data Link Diabetes Drug Class to Gallbladder DiseaseAugust 30th, 2022
